Revolution Medicines (RVMD) Times Interest Earned (2019 - 2026)

Revolution Medicines (RVMD) recorded quarterly Times Interest Earned of -$36.5 in Q1 2026, up 23.27% quarter-over-quarter from -$47.57 in Q4 2025.

Revolution Medicines (RVMD) Times Interest Earned (2019 - 2026) Analysis & Trends

Revolution Medicines' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$36.5 for Q1 2026.

In Q1 2026, Times Interest Earned changed N/A year-over-year to -$36.5; the TTM figure through Mar 2026 stood at -$38.89 (changed N/A YoY), while the FY2025 annual figure was -$6420.9, changed N/A from the prior year.
Times Interest Earned was -$36.5 for Q1 2026 at Revolution Medicines, up from -$47.57 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of -$27.59 in Q3 2025 to a low of -$50.15 in Q1 2024.
Historically, Times Interest Earned has averaged -$40.45 across 3 years, with a median of -$42.04 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Revolution Medicines	32.33 Bn	32.33 Bn	-	-36.50

Download Data